Rising diabetes rates signal an operational gap: the programs that measure how patients are doing need better reach. Phone- and SMS-first surveys, multilingual delivery, and conditional escalation close the gap between intent and reach so care teams see the patients who most need help.
PROMIS-29 explained in plain language: the seven domains, how T-scores work, how it compares with PROMIS-43, -57 and CAT, and when it is the right fit.
A step-by-step guide to running PROMIS surveys through IVR: preparing items for voice, call schedules, retries, scoring, and getting the data to your team.
Is phone delivery right for your PROMIS program? A plain look at the benefits, the real challenges, and the practices that make phone-based PROMIS surveys work.
Clinics often confuse willingness to share smartphone health data with readiness to enroll in passive monitoring. The operational gaps – consent, channel choice, and language access – determine whether PRO collection actually succeeds, and those gaps are fixable with deliberate design choices.
Compare PROMIS pain interference and pain intensity, plus physical function, sleep, fatigue, and PROMIS-29, and learn how to collect them between visits by phone and text.
PROMIS measures come from HealthMeasures; vendors supply the delivery platform. Learn the licensing paths and the questions to ask before your clinical research launches.
A buyer checklist for PROMIS software: CAT and short forms via the HealthMeasures API, T-score scoring, languages, channels, exports, EHR and EDC integration, and alerts.
A plain-language guide to PROMIS measures: domains, short forms, CAT, PROMIS-29, Global Health, and T scores, plus how clinics and researchers put them to work.
Mobile apps can administer PROMIS, but many patients will not install one. Learn how phone and SMS-to-secure-link options help reach older and underserved patients.
Patient-reported outcome (PRO) data is only useful if it reflects what people actually do between visits. A single headline satisfaction score can mask three operational realities: patients stop and restart therapies for cost or side effects, different age groups answer on different channels, and stigma…